LP-003 Injection

BIOLOGICAL4 trials

Sponsors

Longbio Pharma, Longbio Pharma (Suzhou) Co., Ltd.

Conditions

Allergic AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)Food AllergyPeanut AllergiesWheat Hypersensitivity

Phase 2

A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Not yet recruitingNCT07313917

Longbio PharmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Start: 2026-01-20End: 2027-09-30Target: 150Updated: 2026-02-06

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

RecruitingNCT07342803

Longbio PharmaAllergic Asthma

Start: 2025-01-25End: 2029-09-30Target: 200Updated: 2026-01-15

Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients

Not yet recruitingNCT07785063

Longbio Pharma (Suzhou) Co., Ltd.Peanut Allergies

Start: 2026-09-01End: 2029-11-01Target: 80Updated: 2026-08-25

A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy

Not yet recruitingNCT07816432

Longbio Pharma (Suzhou) Co., Ltd.Food Allergy, Wheat Hypersensitivity

Start: 2026-09-04End: 2027-10-15Target: 12Updated: 2026-09-11